Western Blotting Market Is Projected To Grow Due To Rising Number Of Cases With HIV Till 2025: Grand View Research, Inc.

The global western blotting market is anticipated to reach a value of USD 958.4 millionby 2025, according to a new report by Grand View Research, Inc. Rising number of cases with HIV are increasingly contributing towards the growth of western blotting market. This kind of testing is highly effective in detecting HIV among people. According to UNAIDS, nearly 36.7 million people were living with HIV throughout the world in 2015. Such high prevalence of HIV is expected to accelerate the demand for products used in western blotting. Lyme diseases also require western blotting to detect Borrelia burgdorferi (Bb), which causes such diseases. Other diseases which require western blot for detection of specific proteins include mad cow disease, hepatitis, and feline immunodeficiency.

Moreover, significant investments in R&D activities made by pharmaceutical and biotechnology companies are expected to foster growth of western blotting market. According to a news journal, biotech companies spent USD 40.1 billion in 2015 on R&D activities, which was a 16% rise from their 2014 investments. Hence, with rising number of R&D activities, there is an expected rise in the demand for western blotting tests in the near future.

Browse full research report on Western Blotting Market: http://www.grandviewresearch.com/industry-analysis/western-blotting-market   

Further key findings from the study suggest:

  • In 2016, consumables segment held the largest market share and is also expected to exhibit fastest growth over the forecast period owing to rising diagnostic and research-based activities requiring western blotting
  • Amongst the application segment, biomedical & biochemical research contributed towards the largest revenue share in 2016 due to increasing government spending in proteomics research
  • The disease diagnostics segment is anticipated to witness highest CAGR over the forecast period due to rising epidemiology of HIV, Lyme, and other related diseases
  • Amongst the end-use segment, such as academic & research institutes dominated the market in 2016 owing to growing number of research activities conducted by educational institutions supported by government funding
  • The pharmaceutical and biotechnology companies are expected to grow at a significant CAGR over the forecast period due to increasing R&D spending by such companies
  • Some of the key players are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, LI-COR Biosciences, Bio-Techne Corporation, PerkinElmer, Inc., and Merck KGaA.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices  

Grand View Research has segmented the western blotting market on the basis of product, application, end-use and region:

Western Blotting Product Outlook (Revenue, USD Million; 2014 - 2025)
  • Instruments                      
    • Gel Electrophoresis Instruments 
    • Blotting Systems  
      • Semi-Dry Blotting Instruments
      • Wet Blotting Instruments
    • Imagers    
      • Chemiluminescent Imagers
      • Fluorescent Imagers
      • Others
  • Consumables                   
    • Reagents  
    • Kits           
    • Others      
Western Blotting Application Outlook (Revenue, USD Million; 2014 - 2025)
  • Biomedical & Biochemical Research
  • Disease Diagnostics
  • Agriculture
  • Others
Western Blotting End-Use Outlook (Revenue, USD Million; 2014 - 2025)
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Centers
  • Others
Western Blotting Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-western-blotting-market       
                 
About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For more information: http://www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more